Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol versus placebo as add-on to strong opioids for cancer-related pain
2016-000197-38Phase 4Terminated
- Sponsor
- University of Edinburgh
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in breakthrough cancer pain (BTcP) comparing Paracetamol + strong opioids with Placebo + strong opioids (2 arms). Primary endpoint: Clinically relevant change in average pain score. Started Jul 2016; status: terminated.
02
Drugs
acetaminophen
03
Conditions
breakthrough cancer pain (BTcP)
Beyond the preview
Go deeper on 2016-000197-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000197-38.